| Feb 19, 2026 | business | IDEX Corporation operates as a diversified applied solutions provider, organized into three reportable segments: Health & Science Technologies (HST), Fluid & Metering Technologies (FMT), and Fire & Safety/Diversified Products (FSDP). The company manufactures specialized products—including precision fluidics, pumps, valves, flow meters, and fire suppression systems—tailored to customer specifications for niche global markets such as life sciences, semiconductor, energy, and industrial water.
Financial performance is driven by a strategy of organic growth, supplemented by strategic acquisitions, such as the 2024 purchase of Mott Corporation and the 2025 acquisition of Micro-LAM. Management monitors performance primarily through Net sales, Adjusted EBITDA, and Adjusted EBITDA margin. The company maintains a strong liquidity position, supported by a $800 million revolving credit facility and consistent free cash flow generation, which funds capital expenditures, dividends, and share repurchases.
Key risks include exposure to foreign currency fluctuations, inflationary pressures on raw materials, and volume volatility in cyclical end markets like semiconductor OEM and industrial sectors. The company mitigates these through pricing initiatives and cost-containment measures. As of year-end 2025, IDEX remains in compliance with all financial covenants, maintaining a stable credit profile with investment-grade ratings from S&P, Moody’s, and Fitch. |
|---|
| Feb 19, 2026 | mda | IDEX Corporation reported 2025 net sales of $3.46 billion, a 6% increase driven by acquisitions, notably Mott Corporation, and positive pricing across all segments. Organic sales growth was modest at 1%, as price increases were largely offset by volume declines in the Fluid & Metering Technologies (FMT) and Fire & Safety/Diversified Products (FSDP) segments. While adjusted diluted EPS rose 1% to $7.95, reported EPS fell 3% to $6.41, impacted by higher interest expenses from acquisition financing and increased amortization.
The company’s performance remains bifurcated by end-market demand. The Health & Science Technologies (HST) segment benefited from robust activity in data centers, semiconductors, and defense. Conversely, the FMT and FSDP segments faced headwinds from stagnant industrial markets, softer chemical and energy demand, and subdued capital spending in dispensing and international fire markets.
Management continues to prioritize its 80/20 operating framework to drive productivity and margin expansion. Liquidity remains strong, with $580 million in cash and significant revolving facility availability. Capital deployment remains balanced, characterized by $248 million in share repurchases and a 3% dividend increase. Looking ahead, IDEX expects continued growth in HST, while monitoring persistent weakness in core industrial and automotive sectors. |
|---|
| Feb 19, 2026 | risk_factors | IDEX Corporation’s financial performance is heavily tied to global industrial activity, capacity utilization, and capital spending levels across its niche markets. As an applied solutions provider, the company faces significant exposure to macroeconomic volatility, including fluctuations in the U.S. Dollar, which impacts the translation of international results. Demand is currently bifurcated: while the Health & Science Technologies (HST) segment benefits from robust growth in data centers, semiconductors, and defense, the industrial, automotive, and chemical sectors remain sluggish or flat.
Operational risks include the successful integration of bolt-on acquisitions, such as Mott Corporation and Micro-LAM, and the execution of its 80/20 operating framework to drive productivity. The company is also sensitive to inflationary pressures on raw materials and components, which it attempts to mitigate through pricing actions. Financial risks are managed through a balanced capital deployment strategy, though the company remains subject to interest rate fluctuations on its floating-rate debt. Furthermore, IDEX faces evolving regulatory risks, including international tax developments like the OECD’s Pillar Two global minimum tax, and must maintain compliance with strict financial covenants, including a maximum leverage ratio of 3.50 to 1, to support its ongoing capital allocation and share repurchase programs. |
|---|
